Matthew E. Ros
CIK: 0001461613
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JSPR
Jasper Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Ros Matthew E
Ros Matthew E (SEC CIK 0001461613) files insider reports with the SEC as Chief Operating Officer of Jasper Therapeutics, Inc. (JSPR).
Signal8 holds 2 ownership filings by Ros Matthew E (1 Form 3, 1 Form 4), filed on Jul 22, 2026. Those filings report 1 transaction, the latest on Jul 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ros Matthew E's filings is in REDWOOD CITY, CA.
Recent filings by Ros Matthew E
- Jul 20, 2026: Open-market purchase of JSPR derivative securities (Form 4, code P).
Other insiders filing for Jasper Therapeutics, Inc. (JSPR)
- WIGGANS THOMAS G, Director
- Lucas Svetlana, Director
- Crutcher Patrick J, Director
- EMSTER KURT VON, Director
- Shizuru Judith Anne, Director
- Keenan Greg, Chief Medical Officer